Predictions
Baidu Inc. A ADR
Start price
Target price
Perf. (%)
€88.30
27.11.22
27.11.22
-
27.11.23
27.11.23
25.93%
05.12.22
05.12.22
Could be worthwhile Investment >10% per year
American Lithium Corp
Start price
Target price
Perf. (%)
€1.41
26.11.22
26.11.22
€1.00
26.11.23
26.11.23
101.84%
11.01.23
11.01.23
EBIT growth >5% per year expected
Fair valuation
Very low/no dividend yield expected
negative Cash Flow expected
Deutsche Grundstücksauktionen AG
Start price
Target price
Perf. (%)
€17.80
25.11.22
25.11.22
-
25.11.23
25.11.23
-41.57%
26.11.23
26.11.23
Windfall Geotek Inc.
Start price
Target price
Perf. (%)
€0.039
25.11.22
25.11.22
-
25.11.25
25.11.25
-22.08%
24.10.23
24.10.23
Could be very worthwhile Investment >20% year
Qualigen Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.72
22.11.22
22.11.22
-
22.11.23
22.11.23
-66.14%
23.11.23
23.11.23
Could be worthwhile Investment >10% per year
Mineralbrunnen Überkingen-Teinach GmbH & Co. KGaA VZ
Start price
Target price
Perf. (%)
€12.00
21.11.22
21.11.22
€14.00
21.11.23
21.11.23
9.17%
24.07.23
24.07.23
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Fair valuation
High dividend yield expected
Voxeljet AG ADR
Start price
Target price
Perf. (%)
€2.92
20.11.22
20.11.22
€5.00
20.11.23
20.11.23
-34.59%
21.06.23
21.06.23
Could be worthwhile Investment >10% per year
Hive Digital Technologies Ltd.
Start price
Target price
Perf. (%)
€2.18
19.11.22
19.11.22
€2.00
19.11.23
19.11.23
-0.92%
11.01.23
11.01.23
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Bad culture
Bad rating
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.24
17.11.22
17.11.22
-
17.11.23
17.11.23
0.48%
26.12.22
26.12.22
Risky Investment
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€4.62
16.11.22
16.11.22
€1.00
16.11.23
16.11.23
26.73%
23.01.23
23.01.23
Little Investments for future growth
No Innovation
Significant cyclical dependencies
Very bad culture
Agrogeneration
Start price
Target price
Perf. (%)
€0.077
15.11.22
15.11.22
€0.10
15.11.23
15.11.23
-77.33%
16.11.23
16.11.23
Could be worthwhile Investment >10% per year
Santacruz Silver Mining
Start price
Target price
Perf. (%)
€0.38
14.11.22
14.11.22
€0.63
14.11.23
14.11.23
-15.94%
30.11.22
30.11.22
PDS Biotechnology Corp.
Start price
Target price
Perf. (%)
€6.75
14.11.22
14.11.22
€10.00
14.11.23
14.11.23
31.66%
17.11.22
17.11.22
Could be very worthwhile Investment >20% year
Very capable Management
Very good company culture
Few uniques
German Startups Group Berlin Gmbh & Co KGaA
Start price
Target price
Perf. (%)
€1.64
14.11.22
14.11.22
-
14.11.23
14.11.23
-7.93%
15.11.23
15.11.23
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€4.80
14.11.22
14.11.22
-
14.11.23
14.11.23
-13.88%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Hive Digital Technologies Ltd.
Start price
Target price
Perf. (%)
€2.52
14.11.22
14.11.22
-
14.11.23
14.11.23
-19.05%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Intica Systems AG
Start price
Target price
Perf. (%)
€8.25
13.11.22
13.11.22
€10.00
13.11.23
13.11.23
3.03%
26.11.22
26.11.22
Could be very worthwhile Investment >20% year
Strong uniques
Future proof or reliable business model
Very small cyclical dependencies
Crossject S.A.
Start price
Target price
Perf. (%)
€4.04
12.11.22
12.11.22
€4.50
12.11.23
12.11.23
5.82%
13.11.23
13.11.23
Could be worthwhile Investment >10% per year
First Hydrogen Corp.
Start price
Target price
Perf. (%)
€2.94
12.11.22
12.11.22
-
12.12.22
12.12.22
0.68%
13.12.22
13.12.22
Could be worthwhile Investment >10% per year
Uzabase Inc
Start price
Target price
Perf. (%)
€10.10
12.11.22
12.11.22
€4.00
12.11.23
12.11.23
0.99%
26.11.22
26.11.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
EBIT decline/stagnation expected
Oncopeptides AB
Start price
Target price
Perf. (%)
€1.96
12.11.22
12.11.22
€0.000
12.11.23
12.11.23
-17.89%
26.11.22
26.11.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group